1,712 followers
6,688 followers
@ErinGillespieMD @TheWonkologist @jmetlay I’m not AML expert, but on quick read: +4mo OS is good, but not “cure”. Remission rate was non-prespec secondary outcome, likely unadj for mult hypothesis testing. Narrow age range in trial pop’n. Lots of new Rx op
878 followers
Exciting to see so many options for treatment of #AML We’ve come a long way in a very short time. https://t.co/0gdnI90ZZK
968 followers
Was happy to be part of this review on recent drug approvals for #AML with @KatieLaiMD_MPH of @LombardiCancer and with the mentorship and advice of Dr. Judy Karp. @HemOncWomenDocs!! #leusm https://t.co/ksFaYe6duL